Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey
PLOS ONE · 19.10.2023 · 18 (10) · e0293297
DOI: 10.1371/journal.pone.0293297 ↗Kurz gefasst
Querschnittstudie in der Zeitschrift PLOS ONE, online erschienen am 19.10.2023. Verfasst von Jiaqi Fu und 10 weiteren Autor:innen. Beteiligte Einrichtung: School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China. Hauptthemen laut MEDLINE: Sexual and Gender Minorities, HIV Infections, Pre-Exposure Prophylaxis. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 82 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Asian Regional Special Cooperation Fund of National Health Commission of the People’s Republic of China, the Innovative Engineering Program sponsored by Chinese Academy of Medical Sciences.
Abstract (Originalsprache)
Background
Men who have sex with men (MSM) are at high risk of HIV acquisition. Long-acting injectable-pre-exposure prophylaxis (LAI-PrEP), requiring less frequent dosing, is being studied as an alternative method to daily oral HIV PrEP. With the addition of this potential new prevention method, it expands the scope for a wider user choice and is expected to increase the acceptability and uptake of HIV prevention measures. The aim of our study was to explore the willingness to use LAI-PrEP and associated influential factors.
Methods
Participants were recruited from December 2020 to March 2021 through banner advertisements on web- and mobile app-based platforms on Blued, a large gay Chinese social media platform. MSM in our cross-sectional study was HIV-negative and currently lived in mainland China. Participants were asked about their willingness to use LAI-PrEP and reasons why they might be or not be willing to use LAI-PrEP. Multivariable logistic regression was used to analyze the factors associated with the willingness to use LAI-PrEP.
Results
In total, 969 participants met the inclusion criteria and finished the survey. Nearly twenty percent (19.5%) of participants had never tested for HIV; 66.8% of MSM had multiple male partners; and 51.6% of MSM engaged in condomless sex with their partner. About three-fifths (66.3%) of MSM were aware of PrEP, and only 3.9% of MSM had used PrEP before. The willingness to use LAI-PrEP among MSM was 74.0% (95% CI: 71.4%-76.6%). MSM with higher education levels were less likely to show a willingness to use LAI-PrEP (AOR = 0.56, 95%CI: 0.38–0.84). Participants who had a history of HIV test (AOR = 1.68, 95%CI: 1.11–2.55), were willing to use daily oral PrEP (AOR = 10.64, 95%CI:7.43–15.21), had multiple male sexual partners (AOR = 1.33, 95%CI:0.93–1.90), who used rush popper(AOR = 1.49, 95%CI:1.05–2.13), and who were aware of PEP (AOR = 1.66, 95%CI: 1.02–2.70) were more likely to show willingness to use LAI-PrEP.
Conclusions
In our study, MSM had quite high awareness but low uptake of PrEP. As LAI-PrEP is expected to be approved for use in China in the future, our study of MSM highlights the need for key population-focused education programs about PrEP and healthy sexual behavior. This study also provides some evidence for LAI-PrEP use among the Chinese MSM population in the future.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- School of Population Medicine and Public Health, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, China.
- Danlan Public Welfare, Beijing, China.
ORCID-Profile: Jiaqi Fu, Xiaoyou Su
Förderung
- Asian Regional Special Cooperation Fund of National Health Commission of the People’s Republic of China
- the Innovative Engineering Program sponsored by Chinese Academy of Medical Sciences
Zitieren
APA
Fu, J., Dai, Z., Wang, H., Si, M., Chen, X., Wu, Y., Xiao, W., Huang, Y., Yu, F., Mi, G., & Su, X. (2023). Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey. PLOS ONE, 18(10), e0293297. https://doi.org/10.1371/journal.pone.0293297
Vancouver
Fu J, Dai Z, Wang H, Si M, Chen X, Wu Y, et al. Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey. PLOS ONE. 2023;18(10):e0293297. doi:10.1371/journal.pone.0293297
BibTeX
@article{Fu2023,
author = {Fu, Jiaqi and Dai, Zhenwei and Wang, Hao and Si, Mingyu and Chen, Xu and Wu, Yijin and Xiao, Weijun and Huang, Yiman and Yu, Fei and Mi, Guodong and Su, Xiaoyou},
title = {Willingness to use long-acting injectable PrEP among HIV-negative/unknown men who have sex with men in mainland China: A cross-sectional online survey},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {10},
pages = {e0293297},
doi = {10.1371/journal.pone.0293297}
}
EUVIMED